Classification Criteria for Vogt-Koyanagi-Harada Disease
Overview
Affiliations
Purpose: To determine classification criteria for Vogt-Koyanagi-Harada (VKH) disease.
Design: Machine learning of cases with VKH disease and 5 other panuveitides.
Methods: Cases of panuveitides were collected in an informatics-designed preliminary database, and a final database was constructed of cases achieving supermajority agreement on the diagnosis, using formal consensus techniques. Cases were split into a training set and a validation set. Machine learning using multinomial logistic regression was used on the training set to determine a parsimonious set of criteria that minimized the misclassification rate among the panuveitides. The resulting criteria were evaluated on the validation set.
Results: One thousand twelve cases of panuveitides, including 156 cases of early-stage VKH and 103 cases of late-stage VKH, were evaluated. Overall accuracy for panuveitides was 96.3% in the training set and 94.0% in the validation set (95% confidence interval 89.0, 96.8). Key criteria for early-stage VKH included the following: (1) exudative retinal detachment with characteristic appearance on fluorescein angiogram or optical coherence tomography or (2) panuveitis with ≥2 of 5 neurologic symptoms/signs. Key criteria for late-stage VKH included history of early-stage VKH and either (1) sunset glow fundus or (2) uveitis and ≥1 of 3 cutaneous signs. The misclassification rates in the learning and validation sets for early-stage VKH were 8.0% and 7.7%, respectively, and for late-stage VKH 1.0% and 12%, respectively.
Conclusions: The criteria for VKH had a reasonably low misclassification rate and seemed to perform sufficiently well for use in clinical and translational research.
Compositional variation in eye-infiltrating immune cells distinguishes human uveitis subtypes.
Concepcion C, Xia Y, Korshunova Y, Bligard G, Taylor A, Paley M iScience. 2025; 28(3):111928.
PMID: 40060903 PMC: 11889669. DOI: 10.1016/j.isci.2025.111928.
Herbort Jr C, Papasavvas I, Takeuchi M, Usui Y, Hwang D, Sen S J Ophthalmic Inflamm Infect. 2025; 15(1):19.
PMID: 40047826 PMC: 11885766. DOI: 10.1186/s12348-025-00470-0.
Tsutsui H, Fukuda K, Nakajima I, Yamashiro K Cureus. 2025; 17(1):e78209.
PMID: 40026970 PMC: 11870851. DOI: 10.7759/cureus.78209.
Artificial Intelligence in Uveitis: Innovations in Diagnosis and Therapeutic Strategies.
Murugan S, Sanjay S, Somanath A, Mahendradas P, Patil A, Kaur K Clin Ophthalmol. 2024; 18:3753-3766.
PMID: 39703602 PMC: 11656483. DOI: 10.2147/OPTH.S495307.
Effects of pregnancy on the clinical course and treatment outcomes of Vogt-Koyanagi-Harada disease.
Cherukuri N, Murthy S, Tyagi M Indian J Ophthalmol. 2024; 73(Suppl 1):S158-S163.
PMID: 39446841 PMC: 11834918. DOI: 10.4103/IJO.IJO_1251_24.